927 related articles for article (PubMed ID: 28669352)
21. Serum uric acid and the risk of cardiovascular and renal disease.
Borghi C; Rosei EA; Bardin T; Dawson J; Dominiczak A; Kielstein JT; Manolis AJ; Perez-Ruiz F; Mancia G
J Hypertens; 2015 Sep; 33(9):1729-41; discussion 1741. PubMed ID: 26136207
[TBL] [Abstract][Full Text] [Related]
22. Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation.
Johnson RJ; Bakris GL; Borghi C; Chonchol MB; Feldman D; Lanaspa MA; Merriman TR; Moe OW; Mount DB; Sanchez Lozada LG; Stahl E; Weiner DE; Chertow GM
Am J Kidney Dis; 2018 Jun; 71(6):851-865. PubMed ID: 29496260
[TBL] [Abstract][Full Text] [Related]
23. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008.
Zhu Y; Pandya BJ; Choi HK
Am J Med; 2012 Jul; 125(7):679-687.e1. PubMed ID: 22626509
[TBL] [Abstract][Full Text] [Related]
24. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC
Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study.
Jing J; Kielstein JT; Schultheiss UT; Sitter T; Titze SI; Schaeffner ES; McAdams-DeMarco M; Kronenberg F; Eckardt KU; Köttgen A;
Nephrol Dial Transplant; 2015 Apr; 30(4):613-21. PubMed ID: 25395390
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular and renal effects of hyperuricaemia and gout.
Viazzi F; Leoncini G; Pontremoli R
Reumatismo; 2012 Jan; 63(4):253-62. PubMed ID: 22303532
[TBL] [Abstract][Full Text] [Related]
27. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors.
Dehlin M; Jacobsson L; Roddy E
Nat Rev Rheumatol; 2020 Jul; 16(7):380-390. PubMed ID: 32541923
[TBL] [Abstract][Full Text] [Related]
28. The management of hyperuricemia with urate deposition.
Desideri G; Puig JG; Richette P
Curr Med Res Opin; 2015; 31 Suppl 2():27-32. PubMed ID: 26414734
[TBL] [Abstract][Full Text] [Related]
29. An update of genetics, co-morbidities and management of hyperuricaemia.
Zhu C; Sun B; Zhang B; Zhou Z
Clin Exp Pharmacol Physiol; 2021 Oct; 48(10):1305-1316. PubMed ID: 34133780
[TBL] [Abstract][Full Text] [Related]
30. Gout.
Richette P; Bardin T
Lancet; 2010 Jan; 375(9711):318-28. PubMed ID: 19692116
[TBL] [Abstract][Full Text] [Related]
31. Revisiting comorbidities in gout: a cluster analysis.
Richette P; Clerson P; Périssin L; Flipo RM; Bardin T
Ann Rheum Dis; 2015 Jan; 74(1):142-7. PubMed ID: 24107981
[TBL] [Abstract][Full Text] [Related]
32. [URATE AS A POTENTIAL RISK FACTOR OF CARDIOVASCULAR AND RENAL DISEASES].
Butković M
Acta Med Croatica; 2016 Dec; 70(4-5):233-9. PubMed ID: 29087102
[TBL] [Abstract][Full Text] [Related]
33. [The epidemiology and genetic of gout].
Bardin T; Richette P
Presse Med; 2011 Sep; 40(9 Pt 1):830-5. PubMed ID: 21752574
[TBL] [Abstract][Full Text] [Related]
34. Gout in solid organ transplantation: a challenging clinical problem.
Stamp L; Searle M; O'Donnell J; Chapman P
Drugs; 2005; 65(18):2593-611. PubMed ID: 16392875
[TBL] [Abstract][Full Text] [Related]
35. Hyperuricemia, gout, and cardiovascular disease: an update.
Abeles AM
Curr Rheumatol Rep; 2015 Mar; 17(3):13. PubMed ID: 25740704
[TBL] [Abstract][Full Text] [Related]
36. Hyperuricemia and associated diseases.
Becker MA; Jolly M
Rheum Dis Clin North Am; 2006 May; 32(2):275-93, v-vi. PubMed ID: 16716880
[TBL] [Abstract][Full Text] [Related]
37. Coexistent Hyperuricemia and Gout in Rheumatoid Arthritis: Associations With Comorbidities, Disease Activity, and Mortality.
Chiou A; England BR; Sayles H; Thiele GM; Duryee MJ; Baker JF; Singh N; Cannon GW; Kerr GS; Reimold A; Gaffo A; Mikuls TR
Arthritis Care Res (Hoboken); 2020 Jul; 72(7):950-958. PubMed ID: 31074584
[TBL] [Abstract][Full Text] [Related]
38. Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly.
Franchi C; Salerno F; Conca A; Djade CD; Tettamanti M; Pasina L; Corrao S; Marengoni A; Marcucci M; Mannucci PM; Nobili A;
Eur J Intern Med; 2014 Nov; 25(9):847-52. PubMed ID: 25439099
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of contraindications and prescription of pharmacologic therapies for gout.
Keenan RT; O'Brien WR; Lee KH; Crittenden DB; Fisher MC; Goldfarb DS; Krasnokutsky S; Oh C; Pillinger MH
Am J Med; 2011 Feb; 124(2):155-63. PubMed ID: 21295195
[TBL] [Abstract][Full Text] [Related]
40. [Light and Shadow of Hyperuricemia - Neuroprotection, Comorbidities and Therapeutic Strategies].
Pohl H; Vallelian F; Herfs G
Praxis (Bern 1994); 2019 Jun; 108(8):527-533. PubMed ID: 31185840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
